Infectious Disease Control
Lianhua Qingwen -- The Leading TCM In Global Anti-Pandemic Programs
SHIJIAZHUANG, China, March 11, 2021 /PRNewswire/ -- As an epitome of the Chinese civilization, traditional Chinese medicine or TCM, and western medicine, reinforce each other to protect and improve people's health. Since the outbreak of the COVID-19 pandemic,China has been strengthening the inte...
First pocket inhaler for Covid-19 and other viral mutations: DG-Nika AG - a new approach to therapy & proactive protection from the pandemic
BUOCHS, Switzerland, March 11, 2021 /PRNewswire/ -- The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-Ni...
HKBN Enterprise Solutions Offers Prompt Support to Catering Businesses with PHILIPS UV-C Air Disinfection Device
HONG KONG, March 9, 2021 /PRNewswire/ -- Understanding the special operational needs of catering businesses during COVID, HKBN Enterprise Solutions ("HKBNES") has teamed up with Signify (formerly Philips Lighting) to bring to the market – in particular restaurants and catering premises –PHILIPS U...
Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection
OXFORD, United Kingdom and MARLBOROUGH, Mass., March 5, 2021 /PRNewswire/ -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the "Company"), a global, high-growth diagnostics company, announced that today it has released the T-SPOT.COVID test, a CE marked ELISPOT based test intended for qualitative ...
Zymo Research Offers Community-Wide SARS-CoV-2 Detection and Variant Tracking with the Environ™ COVID-19 Wastewater Testing Service
IRVINE, Calif., March 4 2021 /PRNewswire/ -- Zymo Research announced today the launch of itsEnviron™ COVID-19 Wastewater Testing Service. This service facilitates daily community-wide monitoring of COVID-19 cases and variants from a single wastewater sample. Daily case estimates and detected SARS...
e-condLIFE: Cost of human life and business shut down can be minimized with this new prevention technology
* A smarter preventative way to keep family members safe * Peace of mind for staff and customers that the premises are being disinfected 24 hours KUALA LUMPUR, Malaysia, March 3, 2021 /PRNewswire/ -- Since launching inJune 2020, e-condLIFE has been well received and proven to be effective. Dr...
BioVaxys Expanding Technology Platform To Address Emerging SARS-CoV-2 Variants
BVX-0320 and Covid-T to have capability to address UK, Brazilian and South African Virus Variants VANCOUVER, B.C., March 1, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF)("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer app...
VLP BioTech, Inc. Announces an Immunotherapy Designed for the Treatment of Chronic HBV/HDV Infections
- VLP BioTech Has Developed a Vaccine-Based Viral-Entry-Inhibitor for the Treatment of Chronic HBV/HDV. - The Vaccine-Based Treatment Has Significant Advantages Compared to a Peptide-Based, Entry-Inhibitor (Hepcludex). SAN DIEGO, Feb. 24, 2021 /PRNewswire/ -- VLP BioTech, Inc., a private, pre...
Skybox Security Announces 2020 Partner Awards
Channel and distributor partners recognized for commitment to customer excellence and performance SAN JOSE, Calif., Feb. 23, 2021 /PRNewswire/ -- Skybox Security, a global leader in security posture management, today announced the winners of its 2020 Partner Awards. The inaugural award program r...
INOVIO Announces First Subject Dosed in Phase 1B Clinical Trial for its DNA Vaccine Against Lassa Fever, INO-4500, in West Africa
Phase 1B clinical trial is first study for Lassa fever conducted in Africa Goal is for vaccine to be available for emergency use as stockpile product following Phase 2 Progress on INO-4500 reflects INOVIO's focus on and continued commitment to the fight against infectious diseases Trial fully f...
BioVaxys Announces Appointment To Its Scientific Advisory Board
VANCOUVER, B.C., Feb. 22, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), a biotechnology company that is advancing viral and oncology vaccine platforms as well as immuno-diagnostic products, today announced the appointment of Kartik Chandran Ph.D....
Taming the Black Swan: Multilateral diplomacy for sustainable growth in the era of disruption
BANGKOK, Feb. 22, 2021 /PRNewswire/ -- Mr. Don Pramudwinai, Deputy Prime Minister and Minister of Foreign Affairs of the Kingdom of Thailand, and a career diplomat, discussed his vision of the role of diplomacy in Post-Covid 19 sustainability in this opinion piece first published on19 Feb 2021 in...
Seegene's saliva test for COVID-19 is just as effective as NPS test
SEOUL, South Korea, Feb.18, 2021 /PRNewswire/ -- A new study shows that the less-invasive saliva test for COVID-19 gives just as accurate results as those of the nasopharyngeal specimen. A research team at the Department of Laboratory Medicine at Kangwon National University School of Medicine,...
Vax-Immune Diagnostics Takes Innovative Women's Health Diagnostic Device to European Markets to Improve Maternal Group B Strep Testing Processes
HOUSTON, Feb. 18, 2021 /PRNewswire/ -- Vax-Immune Diagnostics announces today it has received CE Mark approval for its first-in-class medical device, LabReady® GBS.LabReady's Group B Strep product is the first in Vax-Immune Diagnostics' lineup of women's health solutions that helps avoid life-th...
EpiVax Announces Participation in International Consortium for Development of Next-Generation Influenza Vaccines (INDIGO)
PROVIDENCE, R.I., Feb. 18, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") today announces its participation in the INDIGO consortium – a partnership of public and private research and development organizations from the EU,India, and United States (funded by the EU and India) with the aim of develop...
RedHill Biopharma Announces First Patient Dosed in U.S. Phase 2/3 COVID-19 Outpatient Study with RHB-107
- The U.S. Phase 2/3 study with once-daily, orally-administered RHB-107 (upamostat) evaluates treatment of patients with symptomatic COVID-19 who do not require hospitalization - the vast majority of patients - RHB-107 is a novel serine protease inhibitor targeting human cell factors involved in...
Indian conglomerate, Godrej & Boyce aims to strengthen Vaccine Cold Chain across the world
Cold Chain Partner to the world's largest covid vaccination drive in India, refrigeration expert Godrej & Boyce launches 'made inIndia' ultra-low-temperature freezers (below -80°C) Offers vaccine cold chain solutions across all temperature bands MUMBAI, India, Feb. 17, 2021 /PRNewswire/ -- Godr...
88% Vaccination Rate Across Yas Island Employees
Abu Dhabi's leading leisure and entertainment destination to be among the first in the world to vaccinate most of itsemployees, signaling its commitment to health and safety ABU DHABI, UAE, Feb. 17, 2021 /PRNewswire/ -- Eighty-eight per cent employees working at attractions, experiences, hotels,...
CGTN:What is China's role in global fight against COVID-19?
BEIJING, Feb. 17, 2021 /PRNewswire/ -- The COVID-19 pandemic, affecting all countries, has underscored both the wayChina addresses a global challenge and its vision for a better world.   As the first major country to have effectively contained the virus and the only major econo...
The Philippines Unveils Unique Advantages in Covid-critical PPE and Medical Supplies Manufacturing at Japanese Business Event
COST EFFICIENT, RESILIENT TALENT POOL AND STRATEGIC POLICY REFORMS PROVIDE INVESTMENT OPPORTUNITIES FORJAPAN AND NEIGHOURING MARKETS TOKYO, Feb. 16, 2021 /PRNewswire/ -- Today, the Philippine government in partnership with the Japan Hygiene Products Industry Association (JHPIA) organized an onli...
Week's Top Stories
Most Reposted
Nine Years of Impact: JULO Disburses USD 1.7 Billion in Digital Financing Across Indonesia
[Picked up by 297 media titles]
2025-12-23 14:23ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 277 media titles]
2025-12-26 12:55ACEN completes transition to 100% renewable energy
[Picked up by 266 media titles]
2025-12-29 18:53CYFIRMA's 2025 Impact Recap Showcases DeCYFIR, Preemptive External Threat Landscape Management Platform, Delivering Measurable Global Defense Against Emerging Threats
[Picked up by 262 media titles]
2025-12-29 09:00ChinaAMC launches Depository Receipts of two Chinese flagship ETFs in Thai exchange
[Picked up by 256 media titles]
2025-12-29 14:27